Prostate Cancer
Racial differences in longitudinal changes in serum prostate-specific antigen levels: The Olmsted County Study and the Flint Men's Health Study - Abstract
November 15, 2013
An assessment of PTV margin based on actual accumulated dose for prostate cancer radiotherapy - Abstract
November 15, 2013
Evaluation of safety and analgesic consumption in patients with advanced cancer treated with zoledronic acid - Abstract
November 14, 2013
"N of 1" case reports in the era of whole-genome sequencing - Abstract
November 14, 2013
Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer - Abstract
November 14, 2013
A prospective pilot study of 89Zr-J591/PSMA positron emission tomography (PET) in men with localized prostate cancer undergoing radical prostatectomy - Abstract
November 14, 2013
18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: A prospective study in 28 patients - Abstract
November 14, 2013
Diffuse osteosclerosis in a patient with prostate cancer - Abstract
November 14, 2013
The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4-10 ng/mL - Abstract
November 14, 2013
Radical prostatectomy. Prognostic value of positive surgical margins in pT2 patients - Abstract
November 14, 2013
Conventional versus automated implantation of loose seeds in prostate brachytherapy: Analysis of dosimetric and clinical results - Abstract
November 14, 2013
Prostate cancer patients continue to have excess mortality up to 15 years after diagnosis - Abstract
November 13, 2013
Distribution of metastatic sites in patients with prostate cancer: A population-based analysis - Abstract
November 13, 2013